• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Dr. Sarah Faris on taking precautions when prescribing postoperative opioids


“Opioids are opioids…they can lead to long-term usage regardless of their FDA class. We really need to be good stewards for our patients,” says Sarah F. Faris, MD.

In this episode, Urology Times® Managing Editor Ben Saylor spoke with Sarah F. Faris, MD. She discusses the recent Urology study, “Persistent Opioid Usage After Urologic Intervention and the Impact of Tramadol,” and how clinicians need to take precaution when prescribing opioids for postoperative care. Faris is an associate professor of surgery at the University of Chicago, Illinois.

Related Content
© 2024 MJH Life Sciences

All rights reserved.